Patents by Inventor Günther Hasenpusch

Günther Hasenpusch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNA for use in the treatment of ligament or tendon lesions
    Patent number: 11065346
    Abstract: Described is a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, for use in the treatment or prevention of ligament or tendon lesions as well as a method for treating ligament or tendon lesions comprising the administration of a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, which is beneficial in the process of healing the ligament or tendon lesions.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: July 20, 2021
    Assignee: ethris GmbH
    Inventors: Günther Hasenpusch, Carsten Rudolph
  • RNA FOR USE IN THE TREATMENT OF LIGAMENT OR TENDON LESIONS
    Publication number: 20190381193
    Abstract: Described is a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, for use in the treatment or prevention of ligament or tendon lesions as well as a method for treating ligament or tendon lesions comprising the administration of a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, which is beneficial in the process of healing the ligament or tendon lesions.
    Type: Application
    Filed: April 29, 2019
    Publication date: December 19, 2019
    Inventors: Günther Hasenpusch, Carsten Rudolph
  • RNA for use in the treatment of ligament or tendon lesions
    Patent number: 10272161
    Abstract: Described is a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, for use in the treatment or prevention of ligament or tendon lesions as well as a method for treating ligament or tendon lesions comprising the administration of a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, which is beneficial in the process of healing the ligament or tendon lesions.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: April 30, 2019
    Assignee: ETHRIS GMBH
    Inventors: Günther Hasenpusch, Carsten Rudolph
  • RNA FOR USE IN THE TREATMENT OF LIGAMENT OR TENDON LESIONS
    Publication number: 20170189552
    Abstract: Described is a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, for use in the treatment or prevention of ligament or tendon lesions as well as a method for treating ligament or tendon lesions comprising the administration of a liquid composition containing naked RNA, such as mRNA encoding a polypeptide, which is beneficial in the process of healing the ligament or tendon lesions.
    Type: Application
    Filed: July 16, 2015
    Publication date: July 6, 2017
    Inventors: Günther HASENPUSCH, Carsten RUDOLPH
  • COMPOSITIONS FOR GASTROINTESTINAL ADMINISTRATION OF RNA
    Publication number: 20170056526
    Abstract: The present invention relates to a pharmaceutical composition comprising a polyribonucleotide (RNA) and a cationic agent, wherein said pharmaceutical composition is formulated as a solid dosage form for administration to the gastrointestinal (GI) tract. The present invention furthermore relates to the use of such a pharmaceutical composition for systemic delivery of RNA and to a method for systemic delivery of RNA to a subject comprising the step of administering such a pharmaceutical composition to the GI tract. Furthermore, the present invention relates to a kit.
    Type: Application
    Filed: December 19, 2014
    Publication date: March 2, 2017
    Inventors: Christian Dohmen, Maximilian Utzinger, Günther Hasenpusch, Carsten Rudolph, Christian Plank